NEWS: ACUITAS THERAPEUTICS NAMED ONE OF BC’S TOP EMPLOYERS (FEB 2024)
The foundation of our success is a positive work culture where everyone feels respected, heard and valued. Our scientific innovation attracts exceptional talent, and our connected and collaborative culture retains them. Click to read information on the award, our news release and an article in The Vancouver Sun.
NEWS: MRNA VACCINATION OF RABBITS ALTERS THE FECUNDITY, BUT NOT THE ATTACHMENT, OF ADULT LXODES SCAPULARIS (JAN 2024)
Congratulations to Acuitas’ Ying Tam, co-author of a recent study featured in the journal Scientific Reports. He collaborated with scientists from Yale University and the University of Pennsylvania studying how 19ISP can interfere with the fecundity of adult I. scapularis, and this finding opens new strategies to reduce tick populations in endemic areas. Click to read more info.
NEWS: A PVS25 MRNA VACCINE INDUCES COMPLETE AND DURABLE TRANSMISSION-BLOCKING IMMUNITY TO PLASMODIUM VIVAX (DEC 2023)
Congratulations to Acuitas’ Ying Tam and Paulo Lin, co-authors of a recent study featured in the journal NPJ Vaccines. They collaborated with scientists from Mahidol University, Ehime University, Tokyo Medical and Dental University and the University of Pennsylvania studying a safe and effective messenger RNA vaccine to eliminate P. vivax malaria. Click to read more info.